Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension

Objectives: Evidence has shown that angiotensin-converting enzyme 2 (ACE2), which can be upregulated after angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) treatment, may play a dual role in the pathogenesis and progression of coronavirus disease 2019 (COVID-19)....

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Cardiovasc Med
Главные авторы: Ma, Jing, Shi, Xiaowei, Yu, Jiong, Lv, Feifei, Wu, Jian, Sheng, Xinyu, Pan, Qiaoling, Yang, Jinfeng, Cao, Hongcui, Li, Lanjuan
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2021
Предметы:
Cardiovascular Medicine
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8202940/
https://ncbi.nlm.nih.gov/pubmed/34136537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.577398
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы